Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Development and Testing of an HIV Prevention Intervention Targeting Black Bisexually Active Men, Funding Opportunity Announcement (FOA) Number PS 08-002, 10249 [E8-3577]

Download as PDF Federal Register / Vol. 73, No. 38 / Tuesday, February 26, 2008 / Notices Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, CDC, 626 Cochrans Mill Road, Pittsburgh, PA 15236, Telephone (412) 386–6465. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 15, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–3569 Filed 2–25–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Development and Testing of an HIV Prevention Intervention Targeting Black Bisexually Active Men, Funding Opportunity Announcement (FOA) Number PS 08–002 mstockstill on PROD1PC66 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 10 a.m.–2 p.m., April 9, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Development and Testing of an HIV Prevention Intervention Targeting Black Bisexually Active Men, FOA Number PS 08–002.’’ Contact Person for More Information: Susan B. Stanton, D.D.S., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., MS D72, Atlanta, GA 30333, Telephone (404) 639–4640. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Aug<31>2005 19:29 Feb 25, 2008 Jkt 214001 Dated: February 15, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–3577 Filed 2–25–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Agriculture Disease and Injury Research, Program Announcement (PA) PAR 006–057 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 9 a.m.–5 p.m., March 27, 2008 (Closed). 9 a.m.–5 p.m., March 28, 2008 (Closed). Place: Marriott Waterfront, 80 Compromise Street, Annapolis, MD 21401. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Centers for Agriculture Disease and Injury Research, PA PAR 006–057.’’ Contact Person for More Information: Stephen Olenchock, PhD, Scientific Review Administrator, Office of Extramural Coordination and Special Projects, National Institute for Occupational Safety and Health, CDC, 1095 Willowdale Road, Morgantown, WV 26505, Telephone (304) 285–6271. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 19, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–3589 Filed 2–25–08; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 10249 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services Privacy Act of 1974; Report of a Modified or Altered System of Records Department of Health and Human Services (HHS), Center for Medicare & Medicaid Services (CMS). ACTION: Notice of a Modified or Altered System of Records (SOR). AGENCY: SUMMARY: In accordance with the requirements of the Privacy Act of 1974, we are proposing to modify or alter existing system of records titled, ‘‘Enrollment Data Base (EDB), System No. 09–70–0502, last modified 67 Federal Register 3203 (January 23, 2002). The EDB currently maintains enrollment-related data, data elements pertaining to Medicare Secondary Payer (MSP), and data regarding Direct billing and Third Part premium collection information for Medicare premiums. We are amending the purpose of the EDB to include maintaining enrollment and entitlement data currently maintained in the following CMS systems of records: Medicare Beneficiary Database (MBD), System No. 09–70–0536; and the Medicare Prescription Drug System (MARx), System No. 09–70–4001. We are modifying the language in published routine use number 1 to permit disclosures to a grantee of a CMS-administered grant program that perform a task for the agency. CMS occasionally contracts out certain of its functions when doing so would contribute to effective and efficient operations. CMS must be able to give a contractor, consultant or grantee whatever information is necessary for the contractor, consultant, or grantee to fulfill its duties. We will modify existing routine use number 5 that permits disclosure to Peer Review Organizations (PRO). Organizations previously referred to as PROs will be renamed to read: Quality Improvement Organizations (QIO). Information will be disclosed to QIOs for health care quality improvement projects. The modified routine use will be renumbered as routine use number 5. We will delete published routine use number 8 authorizing disclosure to support constituent requests made to a congressional representative. If an authorization for the disclosure has been obtained from the data subject, then no routine use is needed. The Privacy Act allows for disclosures with the ‘‘prior written consent’’ of the data subject. E:\FR\FM\26FEN1.SGM 26FEN1

Agencies

[Federal Register Volume 73, Number 38 (Tuesday, February 26, 2008)]
[Notices]
[Page 10249]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-3577]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Development and Testing of an HIV Prevention 
Intervention Targeting Black Bisexually Active Men, Funding Opportunity 
Announcement (FOA) Number PS 08-002

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.
    Time and Date: 10 a.m.-2 p.m., April 9, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Development and Testing of an HIV 
Prevention Intervention Targeting Black Bisexually Active Men, FOA 
Number PS 08-002.''
    Contact Person for More Information: Susan B. Stanton, D.D.S., 
Scientific Review Administrator, CDC, 1600 Clifton Road, NE., MS 
D72, Atlanta, GA 30333, Telephone (404) 639-4640.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-3577 Filed 2-25-08; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.